Rex Cancer Center of Wakefield — Raleigh, North Carolina

Rex Cancer Center of Wakefield is a clinical research site located in Raleigh, North Carolina, United States 27614.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Rex Cancer Center of Wakefield has participated in 12 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation.

Sponsors: NSABP Foundation Inc, SWOG Cancer Research Network, UNC Lineberger Comprehensive Cancer Center.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rex Cancer Center of Wakefield?

Rex Cancer Center of Wakefield has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rex Cancer Center of Wakefield conducted?

Rex Cancer Center of Wakefield has 12 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation.

Is Rex Cancer Center of Wakefield accredited by Crixeo Health?

Yes — Rex Cancer Center of Wakefield holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rex Cancer Center of Wakefield?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.